NEW YORK (Reuters Health) – Women with heavy menstrual bleeding may find that the levonorgestrel-releasing intrauterine system (Mirena; Bayer Schering) is more effective than oral medroxyprogesterone acetate in…
NEW YORK (Reuters Health) – The intensity of bortezomib-based regimens used to treat multiple myeloma in elderly patents can be reduced in order to lessen toxicity, without jeopardizing…
Mark Trahant discusses the transition from traditional mainstream media to social media and its impact on public health messaging, both to the patient and the physician. Mr. Trahant…
Fred Smith discusses the new technologies and tools that the CDC is utilizing to reach physicians and patients. He is a Senior Technologist in the Office of the…
Michelle Samplin-Salgado discusses the mission of AIDS.gov and how they disseminate their message. She is a New Media Strategist with AIDS.gov. For more information, please visit: AIDS.gov. Sponsored…
April D. Ryan discusses the challenges facing urban media, as well as health and wellness in the African American community. She is a White House Correspondent with the…
Dr. Juan Rivera discusses the health disparities faced by Latino patients, as well as the challenges in disseminating health information to the Latino community. He is a cardiologist…
Georges E. Abou Khalil discusses the difficulties of organ procurement within minority populations. He is an analyst with Donate Life. To learn more about Donate Life Hollywood, please…
Punam Keller, PhD, MBA, discusses the importance of convergence to health care; how to get a better return on investment on health care initiatives, as well as utilizing…
In this interview, David E. Henderson, an Emmy Award-winning former CBS News correspondent, accomplished writer, communications strategist, consultant, and speaker, discusses the methods in which physicians can utilize…
NEW YORK (Reuters Health) – Rapid fluid replenishment “remarkably” improves the detection rate of patent foramen ovale (PFO) by transesophageal echocardiography, a multicenter team reports in the American…
NEW YORK (Reuters Health) – After surgically induced remission of Crohn’s disease, treatment with mesalamine reduces the risk of relapse somewhat; sulfasalazine, however, has no apparent benefit, according…
